Kiora Pharmaceuticals (KPRX)
(Delayed Data from NSDQ)
$2.36 USD
-0.03 (-1.26%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $2.40 +0.04 (1.69%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Kiora Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
KPRX 2.36 -0.03(-1.26%)
Will KPRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KPRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KPRX
Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know
KPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for KPRX
Kiora Pharmaceuticals Reports Second Quarter 2025 Results; Company Advances Pipeline with Two ...
Kiora Pharmaceuticals GAAP EPS of -$0.54
Kiora Pharmaceuticals to Showcase Its Retinal Disease Therapeutic Pipeline at The H.C. ...
KPRX Receives Positive Outlook Following New U.S. Patent | KPRX Stock News
Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright